nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—migraine—Prednisone—multiple sclerosis	0.786	1	CpDpCtD
Tizanidine—Arthralgia—Methylprednisolone—multiple sclerosis	0.000146	0.000716	CcSEcCtD
Tizanidine—Anxiety—Methylprednisolone—multiple sclerosis	0.000145	0.000713	CcSEcCtD
Tizanidine—Drowsiness—Methotrexate—multiple sclerosis	0.000145	0.000712	CcSEcCtD
Tizanidine—Rash—Azathioprine—multiple sclerosis	0.000145	0.000711	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000145	0.000711	CcSEcCtD
Tizanidine—Dermatitis—Azathioprine—multiple sclerosis	0.000145	0.00071	CcSEcCtD
Tizanidine—Depression—Methotrexate—multiple sclerosis	0.000145	0.00071	CcSEcCtD
Tizanidine—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000144	0.000709	CcSEcCtD
Tizanidine—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000144	0.000709	CcSEcCtD
Tizanidine—Discomfort—Triamcinolone—multiple sclerosis	0.000144	0.000709	CcSEcCtD
Tizanidine—Discomfort—Methylprednisolone—multiple sclerosis	0.000144	0.000707	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000144	0.000706	CcSEcCtD
Tizanidine—Dry mouth—Triamcinolone—multiple sclerosis	0.000143	0.000702	CcSEcCtD
Tizanidine—Renal failure—Methotrexate—multiple sclerosis	0.000142	0.0007	CcSEcCtD
Tizanidine—Angiopathy—Prednisone—multiple sclerosis	0.000141	0.000694	CcSEcCtD
Tizanidine—Conjunctivitis—Methotrexate—multiple sclerosis	0.000141	0.000692	CcSEcCtD
Tizanidine—Confusional state—Methylprednisolone—multiple sclerosis	0.000141	0.000692	CcSEcCtD
Tizanidine—Immune system disorder—Prednisone—multiple sclerosis	0.000141	0.000691	CcSEcCtD
Tizanidine—Malaise—Betamethasone—multiple sclerosis	0.00014	0.000689	CcSEcCtD
Tizanidine—Malaise—Dexamethasone—multiple sclerosis	0.00014	0.000689	CcSEcCtD
Tizanidine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00014	0.000688	CcSEcCtD
Tizanidine—Oedema—Triamcinolone—multiple sclerosis	0.00014	0.000688	CcSEcCtD
Tizanidine—Vertigo—Dexamethasone—multiple sclerosis	0.00014	0.000687	CcSEcCtD
Tizanidine—Vertigo—Betamethasone—multiple sclerosis	0.00014	0.000687	CcSEcCtD
Tizanidine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00014	0.000686	CcSEcCtD
Tizanidine—Syncope—Dexamethasone—multiple sclerosis	0.00014	0.000686	CcSEcCtD
Tizanidine—Syncope—Betamethasone—multiple sclerosis	0.00014	0.000686	CcSEcCtD
Tizanidine—Arrhythmia—Prednisone—multiple sclerosis	0.000139	0.000683	CcSEcCtD
Tizanidine—Infection—Triamcinolone—multiple sclerosis	0.000139	0.000683	CcSEcCtD
Tizanidine—Sweating—Methotrexate—multiple sclerosis	0.000139	0.000683	CcSEcCtD
Tizanidine—Infection—Methylprednisolone—multiple sclerosis	0.000139	0.000682	CcSEcCtD
Tizanidine—Haematuria—Methotrexate—multiple sclerosis	0.000138	0.000679	CcSEcCtD
Tizanidine—Shock—Triamcinolone—multiple sclerosis	0.000138	0.000677	CcSEcCtD
Tizanidine—Alopecia—Prednisone—multiple sclerosis	0.000138	0.000676	CcSEcCtD
Tizanidine—Shock—Methylprednisolone—multiple sclerosis	0.000137	0.000675	CcSEcCtD
Tizanidine—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000137	0.000673	CcSEcCtD
Tizanidine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000137	0.000673	CcSEcCtD
Tizanidine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000137	0.000672	CcSEcCtD
Tizanidine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000137	0.000672	CcSEcCtD
Tizanidine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000137	0.000672	CcSEcCtD
Tizanidine—Paraesthesia—Prednisolone—multiple sclerosis	0.000137	0.000671	CcSEcCtD
Tizanidine—Tachycardia—Triamcinolone—multiple sclerosis	0.000137	0.000671	CcSEcCtD
Tizanidine—Mental disorder—Prednisone—multiple sclerosis	0.000136	0.00067	CcSEcCtD
Tizanidine—Nausea—Azathioprine—multiple sclerosis	0.000136	0.00067	CcSEcCtD
Tizanidine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000136	0.00067	CcSEcCtD
Tizanidine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000136	0.000666	CcSEcCtD
Tizanidine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000135	0.000665	CcSEcCtD
Tizanidine—Agranulocytosis—Methotrexate—multiple sclerosis	0.000135	0.000664	CcSEcCtD
Tizanidine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000135	0.000663	CcSEcCtD
Tizanidine—Convulsion—Dexamethasone—multiple sclerosis	0.000135	0.000662	CcSEcCtD
Tizanidine—Convulsion—Betamethasone—multiple sclerosis	0.000135	0.000662	CcSEcCtD
Tizanidine—Hypertension—Betamethasone—multiple sclerosis	0.000134	0.00066	CcSEcCtD
Tizanidine—Hypertension—Dexamethasone—multiple sclerosis	0.000134	0.00066	CcSEcCtD
Tizanidine—Asthenia—Mitoxantrone—multiple sclerosis	0.000133	0.000654	CcSEcCtD
Tizanidine—Anxiety—Dexamethasone—multiple sclerosis	0.000132	0.000649	CcSEcCtD
Tizanidine—Anxiety—Betamethasone—multiple sclerosis	0.000132	0.000649	CcSEcCtD
Tizanidine—Discomfort—Dexamethasone—multiple sclerosis	0.000131	0.000643	CcSEcCtD
Tizanidine—Discomfort—Betamethasone—multiple sclerosis	0.000131	0.000643	CcSEcCtD
Tizanidine—Haemoglobin—Methotrexate—multiple sclerosis	0.000131	0.000642	CcSEcCtD
Tizanidine—Hypotension—Methylprednisolone—multiple sclerosis	0.00013	0.000641	CcSEcCtD
Tizanidine—Hepatitis—Methotrexate—multiple sclerosis	0.00013	0.000639	CcSEcCtD
Tizanidine—Haemorrhage—Methotrexate—multiple sclerosis	0.00013	0.000639	CcSEcCtD
Tizanidine—Pharyngitis—Methotrexate—multiple sclerosis	0.000129	0.000634	CcSEcCtD
Tizanidine—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000128	0.000631	CcSEcCtD
Tizanidine—Vision blurred—Prednisone—multiple sclerosis	0.000128	0.000627	CcSEcCtD
Tizanidine—Urethral disorder—Methotrexate—multiple sclerosis	0.000128	0.000627	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000128	0.000627	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000127	0.000625	CcSEcCtD
Tizanidine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000127	0.000624	CcSEcCtD
Tizanidine—Oedema—Dexamethasone—multiple sclerosis	0.000127	0.000624	CcSEcCtD
Tizanidine—Oedema—Betamethasone—multiple sclerosis	0.000127	0.000624	CcSEcCtD
Tizanidine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000127	0.000624	CcSEcCtD
Tizanidine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000127	0.000624	CcSEcCtD
Tizanidine—Infection—Dexamethasone—multiple sclerosis	0.000126	0.00062	CcSEcCtD
Tizanidine—Infection—Betamethasone—multiple sclerosis	0.000126	0.00062	CcSEcCtD
Tizanidine—Ill-defined disorder—Prednisone—multiple sclerosis	0.000126	0.000618	CcSEcCtD
Tizanidine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000126	0.000618	CcSEcCtD
Tizanidine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000125	0.000616	CcSEcCtD
Tizanidine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000125	0.000616	CcSEcCtD
Tizanidine—Anaemia—Prednisone—multiple sclerosis	0.000125	0.000615	CcSEcCtD
Tizanidine—Shock—Dexamethasone—multiple sclerosis	0.000125	0.000614	CcSEcCtD
Tizanidine—Shock—Betamethasone—multiple sclerosis	0.000125	0.000614	CcSEcCtD
Tizanidine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000125	0.000613	CcSEcCtD
Tizanidine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000125	0.000612	CcSEcCtD
Tizanidine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000125	0.000612	CcSEcCtD
Tizanidine—Agitation—Prednisone—multiple sclerosis	0.000125	0.000612	CcSEcCtD
Tizanidine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000124	0.000611	CcSEcCtD
Tizanidine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000124	0.000611	CcSEcCtD
Tizanidine—Tachycardia—Betamethasone—multiple sclerosis	0.000124	0.000609	CcSEcCtD
Tizanidine—Tachycardia—Dexamethasone—multiple sclerosis	0.000124	0.000609	CcSEcCtD
Tizanidine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000123	0.000605	CcSEcCtD
Tizanidine—Erythema multiforme—Methotrexate—multiple sclerosis	0.000123	0.000604	CcSEcCtD
Tizanidine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000123	0.000604	CcSEcCtD
Tizanidine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000123	0.000603	CcSEcCtD
Tizanidine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000123	0.000603	CcSEcCtD
Tizanidine—Malaise—Prednisone—multiple sclerosis	0.000122	0.0006	CcSEcCtD
Tizanidine—Vertigo—Prednisone—multiple sclerosis	0.000122	0.000598	CcSEcCtD
Tizanidine—Syncope—Prednisone—multiple sclerosis	0.000122	0.000597	CcSEcCtD
Tizanidine—Tinnitus—Methotrexate—multiple sclerosis	0.000121	0.000596	CcSEcCtD
Tizanidine—Urticaria—Prednisolone—multiple sclerosis	0.000121	0.000594	CcSEcCtD
Tizanidine—Cardiac disorder—Methotrexate—multiple sclerosis	0.000121	0.000593	CcSEcCtD
Tizanidine—Fatigue—Triamcinolone—multiple sclerosis	0.000121	0.000593	CcSEcCtD
Tizanidine—Fatigue—Methylprednisolone—multiple sclerosis	0.00012	0.000592	CcSEcCtD
Tizanidine—Loss of consciousness—Prednisone—multiple sclerosis	0.000119	0.000585	CcSEcCtD
Tizanidine—Hypotension—Betamethasone—multiple sclerosis	0.000119	0.000583	CcSEcCtD
Tizanidine—Hypotension—Dexamethasone—multiple sclerosis	0.000119	0.000583	CcSEcCtD
Tizanidine—Angiopathy—Methotrexate—multiple sclerosis	0.000118	0.00058	CcSEcCtD
Tizanidine—Vomiting—Mitoxantrone—multiple sclerosis	0.000118	0.00058	CcSEcCtD
Tizanidine—Immune system disorder—Methotrexate—multiple sclerosis	0.000118	0.000577	CcSEcCtD
Tizanidine—Convulsion—Prednisone—multiple sclerosis	0.000117	0.000577	CcSEcCtD
Tizanidine—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000117	0.000576	CcSEcCtD
Tizanidine—Hypertension—Prednisone—multiple sclerosis	0.000117	0.000575	CcSEcCtD
Tizanidine—Rash—Mitoxantrone—multiple sclerosis	0.000117	0.000575	CcSEcCtD
Tizanidine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000117	0.000574	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000116	0.000568	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000116	0.000568	CcSEcCtD
Tizanidine—Arthralgia—Prednisone—multiple sclerosis	0.000115	0.000567	CcSEcCtD
Tizanidine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000115	0.000567	CcSEcCtD
Tizanidine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000115	0.000565	CcSEcCtD
Tizanidine—Anxiety—Prednisone—multiple sclerosis	0.000115	0.000565	CcSEcCtD
Tizanidine—Alopecia—Methotrexate—multiple sclerosis	0.000115	0.000565	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000115	0.000563	CcSEcCtD
Tizanidine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000114	0.000561	CcSEcCtD
Tizanidine—Paraesthesia—Betamethasone—multiple sclerosis	0.000114	0.00056	CcSEcCtD
Tizanidine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000114	0.00056	CcSEcCtD
Tizanidine—Discomfort—Prednisone—multiple sclerosis	0.000114	0.00056	CcSEcCtD
Tizanidine—Mental disorder—Methotrexate—multiple sclerosis	0.000114	0.00056	CcSEcCtD
Tizanidine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000112	0.000551	CcSEcCtD
Tizanidine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000112	0.000549	CcSEcCtD
Tizanidine—Dyspepsia—Betamethasone—multiple sclerosis	0.000112	0.000549	CcSEcCtD
Tizanidine—Urticaria—Triamcinolone—multiple sclerosis	0.000111	0.000546	CcSEcCtD
Tizanidine—Urticaria—Methylprednisolone—multiple sclerosis	0.000111	0.000545	CcSEcCtD
Tizanidine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000111	0.000544	CcSEcCtD
Tizanidine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000111	0.000543	CcSEcCtD
Tizanidine—Oedema—Prednisone—multiple sclerosis	0.000111	0.000543	CcSEcCtD
Tizanidine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00011	0.000542	CcSEcCtD
Tizanidine—Nausea—Mitoxantrone—multiple sclerosis	0.00011	0.000541	CcSEcCtD
Tizanidine—Infection—Prednisone—multiple sclerosis	0.00011	0.00054	CcSEcCtD
Tizanidine—Back pain—Methotrexate—multiple sclerosis	0.00011	0.000538	CcSEcCtD
Tizanidine—Fatigue—Betamethasone—multiple sclerosis	0.000109	0.000538	CcSEcCtD
Tizanidine—Fatigue—Dexamethasone—multiple sclerosis	0.000109	0.000538	CcSEcCtD
Tizanidine—Shock—Prednisone—multiple sclerosis	0.000109	0.000535	CcSEcCtD
Tizanidine—Nervous system disorder—Prednisone—multiple sclerosis	0.000108	0.000533	CcSEcCtD
Tizanidine—Tachycardia—Prednisone—multiple sclerosis	0.000108	0.00053	CcSEcCtD
Tizanidine—Skin disorder—Prednisone—multiple sclerosis	0.000107	0.000528	CcSEcCtD
Tizanidine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000107	0.000525	CcSEcCtD
Tizanidine—Vision blurred—Methotrexate—multiple sclerosis	0.000107	0.000524	CcSEcCtD
Tizanidine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000105	0.000516	CcSEcCtD
Tizanidine—Anaemia—Methotrexate—multiple sclerosis	0.000105	0.000514	CcSEcCtD
Tizanidine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000105	0.000514	CcSEcCtD
Tizanidine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000105	0.000514	CcSEcCtD
Tizanidine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000104	0.00051	CcSEcCtD
Tizanidine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000104	0.00051	CcSEcCtD
Tizanidine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000103	0.000507	CcSEcCtD
Tizanidine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000103	0.000506	CcSEcCtD
Tizanidine—Malaise—Methotrexate—multiple sclerosis	0.000102	0.000502	CcSEcCtD
Tizanidine—Vertigo—Methotrexate—multiple sclerosis	0.000102	0.0005	CcSEcCtD
Tizanidine—Leukopenia—Methotrexate—multiple sclerosis	0.000101	0.000498	CcSEcCtD
Tizanidine—Urticaria—Betamethasone—multiple sclerosis	0.000101	0.000496	CcSEcCtD
Tizanidine—Urticaria—Dexamethasone—multiple sclerosis	0.000101	0.000496	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000101	0.000495	CcSEcCtD
Tizanidine—Dizziness—Prednisolone—multiple sclerosis	0.000101	0.000495	CcSEcCtD
Tizanidine—Asthenia—Triamcinolone—multiple sclerosis	0.0001	0.000493	CcSEcCtD
Tizanidine—Abdominal pain—Dexamethasone—multiple sclerosis	0.0001	0.000493	CcSEcCtD
Tizanidine—Body temperature increased—Betamethasone—multiple sclerosis	0.0001	0.000493	CcSEcCtD
Tizanidine—Abdominal pain—Betamethasone—multiple sclerosis	0.0001	0.000493	CcSEcCtD
Tizanidine—Body temperature increased—Dexamethasone—multiple sclerosis	0.0001	0.000493	CcSEcCtD
Tizanidine—Asthenia—Methylprednisolone—multiple sclerosis	0.0001	0.000492	CcSEcCtD
Tizanidine—Paraesthesia—Prednisone—multiple sclerosis	9.93e-05	0.000488	CcSEcCtD
Tizanidine—Pruritus—Triamcinolone—multiple sclerosis	9.9e-05	0.000487	CcSEcCtD
Tizanidine—Pruritus—Methylprednisolone—multiple sclerosis	9.88e-05	0.000485	CcSEcCtD
Tizanidine—Convulsion—Methotrexate—multiple sclerosis	9.81e-05	0.000482	CcSEcCtD
Tizanidine—Dyspepsia—Prednisone—multiple sclerosis	9.74e-05	0.000478	CcSEcCtD
Tizanidine—Arthralgia—Methotrexate—multiple sclerosis	9.64e-05	0.000474	CcSEcCtD
Tizanidine—Rash—Prednisolone—multiple sclerosis	9.6e-05	0.000472	CcSEcCtD
Tizanidine—Dermatitis—Prednisolone—multiple sclerosis	9.59e-05	0.000471	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	9.58e-05	0.00047	CcSEcCtD
Tizanidine—Diarrhoea—Methylprednisolone—multiple sclerosis	9.56e-05	0.000469	CcSEcCtD
Tizanidine—Fatigue—Prednisone—multiple sclerosis	9.54e-05	0.000468	CcSEcCtD
Tizanidine—Discomfort—Methotrexate—multiple sclerosis	9.53e-05	0.000468	CcSEcCtD
Tizanidine—Constipation—Prednisone—multiple sclerosis	9.46e-05	0.000465	CcSEcCtD
Tizanidine—Confusional state—Methotrexate—multiple sclerosis	9.32e-05	0.000458	CcSEcCtD
Tizanidine—Dizziness—Triamcinolone—multiple sclerosis	9.26e-05	0.000455	CcSEcCtD
Tizanidine—Anaphylactic shock—Methotrexate—multiple sclerosis	9.24e-05	0.000454	CcSEcCtD
Tizanidine—Dizziness—Methylprednisolone—multiple sclerosis	9.24e-05	0.000454	CcSEcCtD
Tizanidine—Infection—Methotrexate—multiple sclerosis	9.18e-05	0.000451	CcSEcCtD
Tizanidine—Feeling abnormal—Prednisone—multiple sclerosis	9.11e-05	0.000448	CcSEcCtD
Tizanidine—Asthenia—Betamethasone—multiple sclerosis	9.11e-05	0.000448	CcSEcCtD
Tizanidine—Asthenia—Dexamethasone—multiple sclerosis	9.11e-05	0.000448	CcSEcCtD
Tizanidine—Nervous system disorder—Methotrexate—multiple sclerosis	9.06e-05	0.000445	CcSEcCtD
Tizanidine—Thrombocytopenia—Methotrexate—multiple sclerosis	9.05e-05	0.000445	CcSEcCtD
Tizanidine—Gastrointestinal pain—Prednisone—multiple sclerosis	9.04e-05	0.000444	CcSEcCtD
Tizanidine—Nausea—Prednisolone—multiple sclerosis	9.04e-05	0.000444	CcSEcCtD
Tizanidine—Pruritus—Dexamethasone—multiple sclerosis	8.99e-05	0.000441	CcSEcCtD
Tizanidine—Pruritus—Betamethasone—multiple sclerosis	8.99e-05	0.000441	CcSEcCtD
Tizanidine—Skin disorder—Methotrexate—multiple sclerosis	8.98e-05	0.000441	CcSEcCtD
Tizanidine—Hyperhidrosis—Methotrexate—multiple sclerosis	8.94e-05	0.000439	CcSEcCtD
Tizanidine—Vomiting—Triamcinolone—multiple sclerosis	8.9e-05	0.000437	CcSEcCtD
Tizanidine—Vomiting—Methylprednisolone—multiple sclerosis	8.88e-05	0.000436	CcSEcCtD
Tizanidine—Rash—Triamcinolone—multiple sclerosis	8.83e-05	0.000434	CcSEcCtD
Tizanidine—Dermatitis—Triamcinolone—multiple sclerosis	8.82e-05	0.000433	CcSEcCtD
Tizanidine—Rash—Methylprednisolone—multiple sclerosis	8.81e-05	0.000433	CcSEcCtD
Tizanidine—Dermatitis—Methylprednisolone—multiple sclerosis	8.8e-05	0.000432	CcSEcCtD
Tizanidine—Urticaria—Prednisone—multiple sclerosis	8.79e-05	0.000432	CcSEcCtD
Tizanidine—Body temperature increased—Prednisone—multiple sclerosis	8.74e-05	0.00043	CcSEcCtD
Tizanidine—Abdominal pain—Prednisone—multiple sclerosis	8.74e-05	0.00043	CcSEcCtD
Tizanidine—Diarrhoea—Dexamethasone—multiple sclerosis	8.69e-05	0.000427	CcSEcCtD
Tizanidine—Diarrhoea—Betamethasone—multiple sclerosis	8.69e-05	0.000427	CcSEcCtD
Tizanidine—Hypotension—Methotrexate—multiple sclerosis	8.64e-05	0.000424	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	8.42e-05	0.000414	CcSEcCtD
Tizanidine—Dizziness—Dexamethasone—multiple sclerosis	8.4e-05	0.000413	CcSEcCtD
Tizanidine—Dizziness—Betamethasone—multiple sclerosis	8.4e-05	0.000413	CcSEcCtD
Tizanidine—Nausea—Triamcinolone—multiple sclerosis	8.31e-05	0.000408	CcSEcCtD
Tizanidine—Paraesthesia—Methotrexate—multiple sclerosis	8.3e-05	0.000408	CcSEcCtD
Tizanidine—Nausea—Methylprednisolone—multiple sclerosis	8.3e-05	0.000408	CcSEcCtD
Tizanidine—Dyspnoea—Methotrexate—multiple sclerosis	8.24e-05	0.000405	CcSEcCtD
Tizanidine—Somnolence—Methotrexate—multiple sclerosis	8.22e-05	0.000404	CcSEcCtD
Tizanidine—Hypersensitivity—Prednisone—multiple sclerosis	8.15e-05	0.0004	CcSEcCtD
Tizanidine—Dyspepsia—Methotrexate—multiple sclerosis	8.14e-05	0.0004	CcSEcCtD
Tizanidine—Vomiting—Dexamethasone—multiple sclerosis	8.07e-05	0.000397	CcSEcCtD
Tizanidine—Vomiting—Betamethasone—multiple sclerosis	8.07e-05	0.000397	CcSEcCtD
Tizanidine—Rash—Betamethasone—multiple sclerosis	8.01e-05	0.000393	CcSEcCtD
Tizanidine—Rash—Dexamethasone—multiple sclerosis	8.01e-05	0.000393	CcSEcCtD
Tizanidine—Dermatitis—Betamethasone—multiple sclerosis	8e-05	0.000393	CcSEcCtD
Tizanidine—Dermatitis—Dexamethasone—multiple sclerosis	8e-05	0.000393	CcSEcCtD
Tizanidine—Fatigue—Methotrexate—multiple sclerosis	7.97e-05	0.000392	CcSEcCtD
Tizanidine—Asthenia—Prednisone—multiple sclerosis	7.94e-05	0.00039	CcSEcCtD
Tizanidine—Pruritus—Prednisone—multiple sclerosis	7.83e-05	0.000384	CcSEcCtD
Tizanidine—Feeling abnormal—Methotrexate—multiple sclerosis	7.62e-05	0.000374	CcSEcCtD
Tizanidine—Diarrhoea—Prednisone—multiple sclerosis	7.57e-05	0.000372	CcSEcCtD
Tizanidine—Gastrointestinal pain—Methotrexate—multiple sclerosis	7.56e-05	0.000371	CcSEcCtD
Tizanidine—Nausea—Dexamethasone—multiple sclerosis	7.54e-05	0.000371	CcSEcCtD
Tizanidine—Nausea—Betamethasone—multiple sclerosis	7.54e-05	0.000371	CcSEcCtD
Tizanidine—Urticaria—Methotrexate—multiple sclerosis	7.34e-05	0.000361	CcSEcCtD
Tizanidine—Dizziness—Prednisone—multiple sclerosis	7.31e-05	0.000359	CcSEcCtD
Tizanidine—Body temperature increased—Methotrexate—multiple sclerosis	7.31e-05	0.000359	CcSEcCtD
Tizanidine—Abdominal pain—Methotrexate—multiple sclerosis	7.31e-05	0.000359	CcSEcCtD
Tizanidine—Vomiting—Prednisone—multiple sclerosis	7.03e-05	0.000346	CcSEcCtD
Tizanidine—Rash—Prednisone—multiple sclerosis	6.97e-05	0.000343	CcSEcCtD
Tizanidine—Dermatitis—Prednisone—multiple sclerosis	6.97e-05	0.000342	CcSEcCtD
Tizanidine—Hypersensitivity—Methotrexate—multiple sclerosis	6.81e-05	0.000335	CcSEcCtD
Tizanidine—Asthenia—Methotrexate—multiple sclerosis	6.63e-05	0.000326	CcSEcCtD
Tizanidine—Nausea—Prednisone—multiple sclerosis	6.57e-05	0.000323	CcSEcCtD
Tizanidine—Pruritus—Methotrexate—multiple sclerosis	6.54e-05	0.000321	CcSEcCtD
Tizanidine—Diarrhoea—Methotrexate—multiple sclerosis	6.32e-05	0.000311	CcSEcCtD
Tizanidine—Dizziness—Methotrexate—multiple sclerosis	6.11e-05	0.0003	CcSEcCtD
Tizanidine—Vomiting—Methotrexate—multiple sclerosis	5.88e-05	0.000289	CcSEcCtD
Tizanidine—Rash—Methotrexate—multiple sclerosis	5.83e-05	0.000286	CcSEcCtD
Tizanidine—Dermatitis—Methotrexate—multiple sclerosis	5.82e-05	0.000286	CcSEcCtD
Tizanidine—Nausea—Methotrexate—multiple sclerosis	5.49e-05	0.00027	CcSEcCtD
Tizanidine—ADRA2C—Signaling Pathways—TAGAP—multiple sclerosis	1.76e-05	0.00164	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—CCL5—multiple sclerosis	1.73e-05	0.00161	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—CCR1—multiple sclerosis	1.72e-05	0.0016	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—CXCL13—multiple sclerosis	1.72e-05	0.0016	CbGpPWpGaD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	1.71e-05	0.00159	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—GPR65—multiple sclerosis	1.71e-05	0.00159	CbGpPWpGaD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	1.67e-05	0.00156	CbGpPWpGaD
Tizanidine—ADRA2B—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	1.67e-05	0.00156	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR ligand binding—CCR5—multiple sclerosis	1.67e-05	0.00155	CbGpPWpGaD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	1.66e-05	0.00155	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—LINGO1—multiple sclerosis	1.65e-05	0.00154	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—S1PR1—multiple sclerosis	1.65e-05	0.00154	CbGpPWpGaD
Tizanidine—ADRA2A—G alpha (i) signalling events—POMC—multiple sclerosis	1.63e-05	0.00152	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—ITGA4—multiple sclerosis	1.63e-05	0.00152	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—CXCL10—multiple sclerosis	1.63e-05	0.00152	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—IFNB1—multiple sclerosis	1.62e-05	0.00151	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—GPC5—multiple sclerosis	1.61e-05	0.00149	CbGpPWpGaD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	1.6e-05	0.00149	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CYP27B1—multiple sclerosis	1.59e-05	0.00148	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CYP24A1—multiple sclerosis	1.59e-05	0.00148	CbGpPWpGaD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	1.56e-05	0.00146	CbGpPWpGaD
Tizanidine—ADRA2A—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	1.56e-05	0.00146	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CXCL13—multiple sclerosis	1.56e-05	0.00145	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CCR1—multiple sclerosis	1.56e-05	0.00145	CbGpPWpGaD
Tizanidine—ADRA2C—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	1.56e-05	0.00145	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—CCR5—multiple sclerosis	1.56e-05	0.00145	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—PTGER4—multiple sclerosis	1.56e-05	0.00145	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—S1PR1—multiple sclerosis	1.54e-05	0.00144	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—CXCR3—multiple sclerosis	1.5e-05	0.0014	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—GPC5—multiple sclerosis	1.5e-05	0.0014	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—RRM1—multiple sclerosis	1.49e-05	0.00138	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—IL2RA—multiple sclerosis	1.47e-05	0.00137	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—CCL3—multiple sclerosis	1.47e-05	0.00137	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—CCR2—multiple sclerosis	1.46e-05	0.00136	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GPC5—multiple sclerosis	1.46e-05	0.00136	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—PTGER4—multiple sclerosis	1.45e-05	0.00135	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TAGAP—multiple sclerosis	1.43e-05	0.00133	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—PTGER4—multiple sclerosis	1.41e-05	0.00132	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—CCL5—multiple sclerosis	1.4e-05	0.00131	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—CXCR3—multiple sclerosis	1.4e-05	0.00131	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—RGS1—multiple sclerosis	1.4e-05	0.00131	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—IL2RA—multiple sclerosis	1.37e-05	0.00128	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—CCL3—multiple sclerosis	1.37e-05	0.00128	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—CCR2—multiple sclerosis	1.37e-05	0.00127	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—CXCR3—multiple sclerosis	1.36e-05	0.00127	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—CNR1—multiple sclerosis	1.35e-05	0.00126	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—GPR65—multiple sclerosis	1.33e-05	0.00124	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—CCR2—multiple sclerosis	1.33e-05	0.00124	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PTGER4—multiple sclerosis	1.32e-05	0.00123	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—RGS1—multiple sclerosis	1.31e-05	0.00122	CbGpPWpGaD
Tizanidine—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	1.3e-05	0.00121	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR ligand binding—POMC—multiple sclerosis	1.3e-05	0.00121	CbGpPWpGaD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	1.3e-05	0.00121	CbGpPWpGaD
Tizanidine—ADRA2B—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	1.28e-05	0.00119	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—CXCR3—multiple sclerosis	1.27e-05	0.00119	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR ligand binding—CCL2—multiple sclerosis	1.27e-05	0.00119	CbGpPWpGaD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	1.27e-05	0.00118	CbGpPWpGaD
Tizanidine—ADRA2A—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	1.27e-05	0.00118	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—CCR5—multiple sclerosis	1.26e-05	0.00118	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—CNR1—multiple sclerosis	1.26e-05	0.00117	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—S1PR1—multiple sclerosis	1.25e-05	0.00117	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SRM—multiple sclerosis	1.25e-05	0.00116	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—GPR65—multiple sclerosis	1.24e-05	0.00116	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—CCR2—multiple sclerosis	1.24e-05	0.00115	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—CNR1—multiple sclerosis	1.22e-05	0.00114	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—GPC5—multiple sclerosis	1.22e-05	0.00113	CbGpPWpGaD
Tizanidine—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	1.22e-05	0.00113	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CCR1—multiple sclerosis	1.22e-05	0.00113	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CXCL13—multiple sclerosis	1.22e-05	0.00113	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—POMC—multiple sclerosis	1.22e-05	0.00113	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—CXCL10—multiple sclerosis	1.21e-05	0.00113	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—RRM1—multiple sclerosis	1.21e-05	0.00112	CbGpPWpGaD
Tizanidine—ADRA2C—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	1.19e-05	0.00111	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—CCL2—multiple sclerosis	1.19e-05	0.00111	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PTGER4—multiple sclerosis	1.18e-05	0.0011	CbGpPWpGaD
Tizanidine—CYP1A2—Biological oxidations—POMC—multiple sclerosis	1.16e-05	0.00108	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—CNR1—multiple sclerosis	1.14e-05	0.00107	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—CXCR3—multiple sclerosis	1.14e-05	0.00106	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CXCL13—multiple sclerosis	1.14e-05	0.00106	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CCR1—multiple sclerosis	1.14e-05	0.00106	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—CXCL10—multiple sclerosis	1.13e-05	0.00106	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—IL2RA—multiple sclerosis	1.11e-05	0.00104	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CCL3—multiple sclerosis	1.11e-05	0.00104	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—CCR2—multiple sclerosis	1.11e-05	0.00103	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—CXCL10—multiple sclerosis	1.1e-05	0.00103	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PTGER4—multiple sclerosis	1.07e-05	0.000998	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—RGS1—multiple sclerosis	1.06e-05	0.000991	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—ALB—multiple sclerosis	1.06e-05	0.000989	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—CCL5—multiple sclerosis	1.05e-05	0.000973	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CXCR3—multiple sclerosis	1.04e-05	0.000964	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—CXCL10—multiple sclerosis	1.03e-05	0.000959	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—CNR1—multiple sclerosis	1.02e-05	0.000953	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—GPR65—multiple sclerosis	1.01e-05	0.00094	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CCR2—multiple sclerosis	1.01e-05	0.000937	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—ALB—multiple sclerosis	9.92e-06	0.000923	CbGpPWpGaD
Tizanidine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	9.89e-06	0.00092	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—POMC—multiple sclerosis	9.88e-06	0.00092	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—CCL5—multiple sclerosis	9.77e-06	0.000909	CbGpPWpGaD
Tizanidine—ADRA2A—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	9.7e-06	0.000903	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—CCL2—multiple sclerosis	9.67e-06	0.0009	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—CCL5—multiple sclerosis	9.49e-06	0.000884	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—CCR5—multiple sclerosis	9.42e-06	0.000877	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CNR1—multiple sclerosis	9.29e-06	0.000865	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—IL2RA—multiple sclerosis	9.28e-06	0.000864	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCR1—multiple sclerosis	9.23e-06	0.000859	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CXCL13—multiple sclerosis	9.23e-06	0.000859	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—CXCL10—multiple sclerosis	9.22e-06	0.000858	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—CCL5—multiple sclerosis	8.87e-06	0.000826	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—CCR5—multiple sclerosis	8.8e-06	0.000819	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	8.79e-06	0.000819	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	8.79e-06	0.000819	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—IL2RA—multiple sclerosis	8.67e-06	0.000807	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CCL3—multiple sclerosis	8.67e-06	0.000807	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—IL2—multiple sclerosis	8.61e-06	0.000802	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.59e-06	0.0008	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—CCR5—multiple sclerosis	8.55e-06	0.000796	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—BCHE—multiple sclerosis	8.54e-06	0.000795	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—IL2RA—multiple sclerosis	8.43e-06	0.000785	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CXCL10—multiple sclerosis	8.37e-06	0.000779	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PTGER4—multiple sclerosis	8.35e-06	0.000777	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PGR—multiple sclerosis	8.22e-06	0.000765	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CCL3—multiple sclerosis	8.1e-06	0.000754	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CXCR3—multiple sclerosis	8.06e-06	0.00075	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—ALB—multiple sclerosis	8.06e-06	0.00075	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—IL2—multiple sclerosis	8.04e-06	0.000749	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GPC5—multiple sclerosis	8.04e-06	0.000749	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—CCR5—multiple sclerosis	7.99e-06	0.000744	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CD28—multiple sclerosis	7.99e-06	0.000743	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—CCL5—multiple sclerosis	7.93e-06	0.000738	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—IL2RA—multiple sclerosis	7.87e-06	0.000733	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CCR2—multiple sclerosis	7.84e-06	0.00073	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PTGER4—multiple sclerosis	7.8e-06	0.000726	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PGR—multiple sclerosis	7.68e-06	0.000715	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CXCR3—multiple sclerosis	7.53e-06	0.000701	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CD28—multiple sclerosis	7.46e-06	0.000694	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—POMC—multiple sclerosis	7.36e-06	0.000685	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CCR2—multiple sclerosis	7.32e-06	0.000682	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CNR1—multiple sclerosis	7.24e-06	0.000674	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CCL5—multiple sclerosis	7.2e-06	0.000671	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—CCR5—multiple sclerosis	7.15e-06	0.000665	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—IL2RA—multiple sclerosis	7.04e-06	0.000656	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—BCHE—multiple sclerosis	6.93e-06	0.000645	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—POMC—multiple sclerosis	6.88e-06	0.00064	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CNR1—multiple sclerosis	6.76e-06	0.000629	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—TGFB1—multiple sclerosis	6.72e-06	0.000625	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—POMC—multiple sclerosis	6.68e-06	0.000622	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—RRM1—multiple sclerosis	6.66e-06	0.00062	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—MAPK1—multiple sclerosis	6.59e-06	0.000613	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCL3—multiple sclerosis	6.58e-06	0.000612	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—CCL2—multiple sclerosis	6.54e-06	0.000609	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—IL2—multiple sclerosis	6.53e-06	0.000608	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CXCL10—multiple sclerosis	6.52e-06	0.000606	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CCR5—multiple sclerosis	6.49e-06	0.000604	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—IL2RA—multiple sclerosis	6.4e-06	0.000595	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PTGER4—multiple sclerosis	6.33e-06	0.000589	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—TGFB1—multiple sclerosis	6.27e-06	0.000584	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—POMC—multiple sclerosis	6.24e-06	0.000581	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PGR—multiple sclerosis	6.24e-06	0.00058	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—MAPK1—multiple sclerosis	6.15e-06	0.000573	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CXCR3—multiple sclerosis	6.12e-06	0.000569	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—CCL2—multiple sclerosis	6.11e-06	0.000569	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CXCL10—multiple sclerosis	6.09e-06	0.000567	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CD28—multiple sclerosis	6.06e-06	0.000564	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCR2—multiple sclerosis	5.95e-06	0.000554	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—TYK2—multiple sclerosis	5.94e-06	0.000553	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CD86—multiple sclerosis	5.7e-06	0.00053	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CCL5—multiple sclerosis	5.61e-06	0.000522	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—POMC—multiple sclerosis	5.59e-06	0.00052	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—TYK2—multiple sclerosis	5.55e-06	0.000516	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CNR1—multiple sclerosis	5.49e-06	0.000511	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—IL2—multiple sclerosis	5.44e-06	0.000507	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CD86—multiple sclerosis	5.32e-06	0.000495	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CCL5—multiple sclerosis	5.24e-06	0.000488	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—SPP1—multiple sclerosis	5.19e-06	0.000483	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.17e-06	0.000481	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—APOE—multiple sclerosis	5.14e-06	0.000478	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—TGFB1—multiple sclerosis	5.1e-06	0.000474	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—IL2—multiple sclerosis	5.08e-06	0.000473	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—POMC—multiple sclerosis	5.07e-06	0.000472	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CCR5—multiple sclerosis	5.05e-06	0.00047	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—MAPK1—multiple sclerosis	5e-06	0.000465	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IL2RA—multiple sclerosis	4.98e-06	0.000464	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CCL2—multiple sclerosis	4.96e-06	0.000462	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CXCL10—multiple sclerosis	4.94e-06	0.00046	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—IL2—multiple sclerosis	4.94e-06	0.00046	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SPP1—multiple sclerosis	4.85e-06	0.000452	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CCR5—multiple sclerosis	4.72e-06	0.000439	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IL2RA—multiple sclerosis	4.65e-06	0.000433	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—IL2—multiple sclerosis	4.62e-06	0.00043	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—APOE—multiple sclerosis	4.6e-06	0.000428	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	4.51e-06	0.000419	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.44e-06	0.000413	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—POMC—multiple sclerosis	4.41e-06	0.000411	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	4.32e-06	0.000402	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—APOE—multiple sclerosis	4.29e-06	0.0004	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	4.26e-06	0.000396	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—APOE—multiple sclerosis	4.17e-06	0.000388	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CD80—multiple sclerosis	4.16e-06	0.000387	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	4.13e-06	0.000384	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.05e-06	0.000377	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—ALB—multiple sclerosis	4.02e-06	0.000374	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	3.95e-06	0.000368	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	3.94e-06	0.000367	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CD80—multiple sclerosis	3.88e-06	0.000361	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	3.86e-06	0.00036	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	3.83e-06	0.000357	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—BCHE—multiple sclerosis	3.83e-06	0.000356	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	3.78e-06	0.000352	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	3.78e-06	0.000352	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	3.75e-06	0.000349	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—POMC—multiple sclerosis	3.69e-06	0.000343	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CCL2—multiple sclerosis	3.61e-06	0.000336	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—POMC—multiple sclerosis	3.58e-06	0.000334	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—MAPK1—multiple sclerosis	3.53e-06	0.000329	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	3.51e-06	0.000327	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	3.49e-06	0.000325	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TYK2—multiple sclerosis	3.28e-06	0.000305	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ALB—multiple sclerosis	3.27e-06	0.000304	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	3.15e-06	0.000294	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	3e-06	0.000279	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	2.93e-06	0.000273	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	2.92e-06	0.000272	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	2.9e-06	0.00027	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	2.87e-06	0.000267	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	2.76e-06	0.000257	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IL2—multiple sclerosis	2.73e-06	0.000254	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—IL6—multiple sclerosis	2.71e-06	0.000253	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	2.66e-06	0.000248	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MMP9—multiple sclerosis	2.58e-06	0.00024	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	2.46e-06	0.000229	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—APOE—multiple sclerosis	2.3e-06	0.000214	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—STAT3—multiple sclerosis	2.29e-06	0.000214	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	2.28e-06	0.000212	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	2.28e-06	0.000212	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	2.23e-06	0.000208	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	2.22e-06	0.000206	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	2.2e-06	0.000205	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MYC—multiple sclerosis	2.13e-06	0.000198	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TGFB1—multiple sclerosis	2.13e-06	0.000198	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	2.1e-06	0.000195	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MAPK1—multiple sclerosis	2.09e-06	0.000194	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—POMC—multiple sclerosis	1.98e-06	0.000184	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	1.86e-06	0.000174	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALB—multiple sclerosis	1.8e-06	0.000168	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	1.73e-06	0.000161	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	1.73e-06	0.000161	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	1.72e-06	0.00016	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	1.69e-06	0.000158	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IL6—multiple sclerosis	1.6e-06	0.000149	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	1.3e-06	0.000121	CbGpPWpGaD
